💊 Médicaments A-Z 🧬 Cibles 🛠 Outils 📚 Guides
Tous les médicaments Classes de médicaments Aires thérapeutiques Effets Indésirables
Guides Glossaire Chronologie
Comparaisons Parcours des médicaments Familles de médicaments
🇺🇸 English 🇰🇷 한국어 🇯🇵 日本語 🇨🇳 中文简体 🇪🇸 Español 🇧🇷 Português 🇮🇳 हिन्दी 🇸🇦 العربية 🇫🇷 Français 🇷🇺 Русский 🇩🇪 Deutsch 🇹🇷 Türkçe 🇻🇳 Tiếng Việt 🇮🇩 Bahasa Indonesia 🇹🇭 ไทย

Technetium Succimer

CHEMBL2110572 Phase 4 Approuvé Small molecule
Half-Life
—
Bioavailability
—
Protein Binding
—
Molecular Weight
— g/mol
LogP
—
Phase
4

Technetium succimer (99mTc-DMSA, dimercaptosuccinic acid) is a renal cortical imaging agent that binds to proximal renal tubular cells, providing high-resolution static scintigraphic images of the renal cortex to assess renal parenchymal integrity and scarring. It is considered the gold standard for detecting renal cortical scarring from pyelonephritis, particularly in children, and for measuring differential renal function. Its high cortical uptake and retention make it ideal for anatomical rather than functional renal assessment.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

HBD / HBA

- / -

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Foire aux questions

Technetium succimer (99mTc-DMSA, dimercaptosuccinic acid) is a renal cortical imaging agent that binds to proximal renal tubular cells, providing high-resolution static scintigraphic images of the renal cortex to assess renal parenchymal integrity and scarring. It is considered the gold standard for detecting renal cortical scarring from pyelonephritis, particularly in children, and for measuring differential renal function. Its high cortical uptake and retention make it ideal for anatomical rather than functional renal assessment.

Yes, Technetium Succimer is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL2110572. Open-access bioactivity database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-02-27.

Avertissement médical

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.